Zentrum fur Refraktive Chirurgie, Munster, Germany.
J Refract Surg. 2011 Sep;27(9):678-85. doi: 10.3928/1081597X-20110317-01. Epub 2011 Mar 31.
To investigate a potential influence of mydriatic eye drops on wavefront sensing with the Zywave aberrometer (Technolas Perfect Vision) in terms of predicted phoropter refraction (PPR) and higher order aberrations (HOA).
In this prospective study, 200 myopic eyes were measured in miosis and pharmacologically induced mydriasis with an aberrometer and automated refraction. One hundred eyes were dilated with tropicamide 0.5%+phenylephrine 2.5% eye drops (tropicamide/phenylephrine group), and the remaining 100 eyes with tropicamide 0.5% (tropicamide only group). The PPR values for a pupil diameter of 3.5 mm in miosis and mydriasis, respectively, were compared and correlated to the corresponding values of automated refraction. Changes in HOAs up to the 4th order were recorded.
Predicted phoropter refraction values obtained in mydriasis were less myopic than in miosis. The spherical equivalent refraction of PPR differed by an average of 0.36 ± 0.36 diopters (D) in the tropicamide/phenylephrine group. In the tropicamide only group, the difference was 0.24 ± 0.43 D. Sphere of PPR differed by an average of 0.33 ± 0.36 D in the tropicamide/phenylephrine group and by an average of 0.24 ± 0.35 D in the tropicamide only group. Patient age had no major influence on the level of difference. Automated refraction yielded a smaller difference in spherical equivalent refraction. Changes in HOA root-mean-square were statistically significant.
The cycloplegic effect of mydriatic eye drops should be taken into account when interpreting aberration measurements and planning a wavefront-guided ablation. Ideally, the use of mydriatic eye drops should be avoided to minimize refractive surprises.
研究扩瞳眼药对 Zywave 像差仪(Technolas Perfect Vision)测量预测检眼镜折射(PPR)和高阶像差(HOA)的潜在影响。
在这项前瞻性研究中,200 只近视眼在睫状肌麻痹和药物性散瞳下用像差仪和自动验光仪进行测量。100 只眼用 0.5%托吡卡胺+2.5%苯肾上腺素滴眼剂(托吡卡胺/苯肾上腺素组)散瞳,其余 100 只眼用 0.5%托吡卡胺散瞳(仅托吡卡胺组)。比较瞳孔直径为 3.5mm 时的缩瞳和散瞳时的 PPR 值,并与自动验光的相应值进行相关分析。记录高达 4 阶的 HOAs 变化。
散瞳时获得的 PPR 近视矫正值比缩瞳时更近视。托吡卡胺/苯肾上腺素组 PPR 的球镜等效屈光度平均相差 0.36 ± 0.36 屈光度(D)。在仅托吡卡胺组,差异为 0.24 ± 0.43 D。PPR 的球镜平均相差 0.33 ± 0.36 D 在托吡卡胺/苯肾上腺素组,平均相差 0.24 ± 0.35 D 在仅托吡卡胺组。患者年龄对差异水平无主要影响。自动验光的球镜等效屈光度差异较小。HOA 均方根的变化具有统计学意义。
在解释像差测量和规划波前引导消融时,应考虑散瞳眼药的散瞳作用。理想情况下,应避免使用散瞳眼药以尽量减少屈光意外。